Sample | Title | Value | Rank |
GSM451635 | M15 - infected MBT/Pas fibroblasts (9 h post inf) | 256.6 | 83 |
GSM451636 | M16 - infected MBT/Pas fibroblasts (9 h post inf) | 350.5 | 87 |
GSM451637 | M17 - infected MBT/Pas fibroblasts (9 h post inf) | 325.3 | 86 |
GSM451632 | M11 - non-infected MBT/Pas fibroblasts | 268.9 | 83 |
GSM451633 | M12 - non-infected MBT/Pas fibroblasts | 182.9 | 78 |
GSM451634 | M13 - non-infected MBT/Pas fibroblasts | 119.3 | 73 |
GSM451629 | B15 - infected BALB/cByJ fibroblasts (9 h post inf) | 257.6 | 83 |
GSM451630 | B16 - infected BALB/cByJ fibroblasts (9 h post inf) | 383.7 | 88 |
GSM451631 | B17 - infected BALB/cByJ fibroblasts (9 h post inf) | 396.4 | 88 |
GSM451626 | B11 - non-infected BALB/cByJ fibroblasts | 224.5 | 80 |
GSM451627 | B12 - non-infected BALB/cByJ fibroblasts | 241 | 82 |
GSM451628 | B13 - non-infected BALB/cByJ fibroblasts | 246.5 | 82 |